Embolization Agents Market Global Analysis & Forecast 2028

The embolization agents market is projected to reach US$ 4,525.75 million by 2028 from US$ 2,714.82 million in 2021; it is expected to grow at a CAGR of 7.6% from 2021 to 2028.

The growth of the market is attributed to the rising incidence of tumors and aneurysms and growing prevalence of hypertension, obesity, smoking, and alcoholism. However, high costs of embolization agents restrain the embolization agents market growth. Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are mostly used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration required for arterial occlusion, embolization agents are classified as temporary or permanent.

In the US, the demand for warts treatment procedures has reduced due to the shift in the focus on COVID-19 treatment. The COVID-19 pandemic has been causing havoc in the global supply chains, consumer markets, and economies. This situation has led to a decline in cardiac procedures carried out in various countries in Asia Pacific. The measures implemented by governments across the world have negatively impacted the embolization agents market growth.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Embolization Agents Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights
Rising Incidence of Tumors and Aneurysms Fuels Embolization Agents Market Growth

According to the National Cancer Institute, in 2020, there were 1,806,590 new cancer cases and 606,520 deaths due to the disease in the US. In 2020, prostate, lung, and colorectal cancers accounted for 43 % of all cancers diagnosed in men. Breast, lung, and colorectal cancers are the three most frequent cancers diagnosed in women. As per the Brain Aneurysm Foundation, Statistics and Facts report, in the US, around 6.5 million people that is 1 in 50 people have an unruptured brain aneurysm. It has also mentioned that 20% of the total people diagnosed with a brain aneurysm have more than one aneurysm. It has further reported that, every year, around 30,000 people in the US suffer from a brain aneurysm rupture and a brain aneurysm rupture takes place every 18 minutes. Further, as per the NHS, every year in the UK, 1 in 12,500 people have a ruptured brain aneurysm in England. Additionally, as per the ‘Unruptured Intracranial Aneurysms Pathogenesis and Individualized Management’ report published in Deutsches Ärzteblatt International in 2020, around 2 million people (adults) in Germany have an unruptured intracranial aneurysm (IA). Embolization agents are used to acutely stop the flow in a blood vessel or vascular territory by the means of mechanical occlusion. Embolizing agents, such as embolic microspheres (beads), are used to restrict the vascular supply to tumors and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. Liquid embolic agents are used to prevent blood supply to aneurysm or tumor. Thus, the increasing prevalence of aneurysms and cancers is creating high demand for embolization agents.

Product-Based Insights

Based on product, the embolization agents market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, and others. The beads/particles segment holds the largest share of the market. However, the coil segment is anticipated to register the highest CAGR during 2021–2028. Coil Embolization is a catheter-based procedure that allows precise occlusion of abnormal blood flow in a blood vessel. The increasing number of cardiac surgeries is propelling the market growth of this segment.

Application - Based Insights

Based on application, the embolization agents market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. The oncology segment holds the largest share of the market and is anticipated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the embolization agents market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The hospitals segment holds the largest market share and is estimated to register the highest CAGR during the forecast period. The market growth for this segment is attributed to the increasing number of hospitals across the world and rapidly growing number of surgical procedures.

Companies operating in the embolization agents market are adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

Embolization Agents Market Regional Insights

The regional trends and factors influencing the Embolization Agents Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Embolization Agents Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Embolization Agents Market Report Scope

Market Players Density: Understanding Its Impact on Business Dynamics

The Embolization Agents Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Embolization Agents Market are:

1. Medtronic
2. Terumo Corporation
3. Cook Medical LLC
4. Boston Scientific Corporation
5. Abbott

Disclaimer: The companies listed above are not ranked in any particular order.

Embolization Agents Market – by Product

• Coils
  • Detachable Coils
  • Pushable Coils
• Beads/ Particles
  • Spherical
  • Non-Spherical
• Plugs
• Detachable Balloons
• Glue
• Sponge
• Liquid Embolics
• Sclerosants
• Precipitating Agents
• Others

Embolization Agents Market – by Application

• Oncology
• Neurology
• Urology
• Cardiology
• Peripheral Vascular Diseases
• Others

Embolization Agents Market – by End User

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Others

Embolization Agents Market– by Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC

• Middle East and Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

• South and Central America (SCAM)

  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• Medtronic
• Terumo Corporation
• Cook Medical LLC
• Boston Scientific Corporation
• Abbott
• Stryker Corporation
• Penumbra, Inc.
• Merit Medical Systems Inc.
• DePuy Synthes
• KANEKA CORPORATION